Skip to main content
Signal8

PERRIGO Co plc (PRGO)

Sector: Pharmaceutical Preparations

Industry: Drug Manufacturers - Specialty & Generic

Perrigo Company plc logo

Perrigo Company plc

NYSE:PRGOHealthcare
+0.89%$15.85
CLOSED
AH$15.85+0.00%vs close
Mkt Cap$2.2B
Float138.24M
O/S138.8M
VOL2.31M sh
$ Vol$36.56M
RVOL0.93×
Inst Own-
SI17.5%
Div Yield7.32%
Dilution
Perrigo Company plc logoNYSE:PRGOClosed$15.85+0.89%
Historical Data
DateOpenHighLowCloseVolume
Nov 6, 202615.5015.9715.2515.852,314,637
Nov 5, 202616.3116.6115.4915.712,875,544
Nov 4, 202615.4416.8015.1215.834,972,089
Nov 3, 202615.5315.7815.3915.702,146,726
Nov 2, 202615.9516.0515.6415.752,007,464
Oct 30, 202616.0716.1415.4215.783,349,349
Oct 29, 202616.0516.2715.7115.902,288,812
Oct 28, 202615.9616.0515.6815.921,710,271
Oct 27, 202615.5616.1815.4716.022,233,160
Oct 26, 202616.0516.2115.7415.821,495,215
Oct 23, 202616.2216.3315.8815.961,555,735
Oct 22, 202615.9916.4515.8916.371,782,795
Oct 21, 202616.0116.1315.5815.912,359,218
Oct 20, 202616.3416.6816.0816.171,765,281
Oct 19, 202616.5916.7916.0216.092,893,905
Oct 16, 202616.5416.6816.2616.632,439,631
Oct 15, 202616.1616.6616.0816.483,308,183
Oct 14, 202615.2916.1715.1315.954,637,057
Oct 13, 202615.1915.7315.1915.371,761,728
Oct 12, 202614.9015.5214.8615.451,840,202
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
Not available
Ratings Distribution
BUY
14
HOLD
21
SELL
1
TOTAL36
Insider Trades
InsiderTypeShares
Parker Geoffrey M. profile photoParker Geoffrey M.Automatic Sell607
Parker Geoffrey M. profile photoParker Geoffrey M.Option Exercise1.3K
Alford Bradley A profile photoAlford Bradley AOption Exercise1.3K
Alford Bradley A profile photoAlford Bradley AAutomatic Sell607
Parker Geoffrey M. profile photoParker Geoffrey M.Option Exercise1.3K
Alford Bradley A profile photoAlford Bradley AOption Exercise1.3K
Shareholders
-
Institutionalⓘ
(352)
0.4%
Insiderⓘ
(21)
0.0%
5%+ Owners
(0)
-
Unattributed (incl. retail)ⓘ
Insider0.4%
Sources: 13F, Form 4, 13D/13GO/S: 138.8M · as of 30 Oct 2026 · SEC cover page
Insiders & Institutional Holders
About

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments.

It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products.

It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands.

The company also offers contract manufacturing services.

It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies.

The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Key Metrics
Market Cap$2.20B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

13F filers report 157.75M shares, more than the 138.80M outstanding, so no percentage is shown. 13F reports lag by a quarter and shares lent to short sellers can be counted twice.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNYSE
CountryIEIE
IPO DateDec 17, 1991
Shares Outstanding138.80M
Authorized Shares
Float138.24M
52-Week Range
$9.23$22.65
$15.85(49th percentile)
Volume
Average Daily Volume2.49M
2.31M today vs 2.49M avg(-7%)

30d Avg

2.49M

60d Avg

2.69M

90d Avg

2.63M

Earnings
Dividend History
TTM Yield
7.32%
Paid quarterly
Annual (LTM)
$1.16
Latest
$0.2900
Nov 27, 26
5Y Growth
+4.19%
per year
Compliance Status
Loading compliance data...